The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Bruker Biospin Corp for $1,751,211.96 on September 30, 2026, for NMR and Q-band electron paramagnetic resonance equipment, with ultimate completion by November 30, 2027.
The order covers two current-generation CCU05 cryoplatform units to replace end-of-life CCU04 systems on existing 600-MHz spectrometers, a 100-W solid-state amplifier with Q-band loop resonator to replace a failing traveling wave tube amplifier on an Excelsys E580 34 GHz EPR spectrometer, and a 600-MHz small-volume cryoprobe with 1H/13C/15N/19F/31P capability. Optional items include a compact Q-band pulsed EPR spectrometer with cryogen-free superconducting magnet and four additional CCU05 cryoplatforms. Equipment is delivered and installed at the NIH main campus in Bethesda. The order originated from a solicitation posted August 4, 2026, with quotations due August 13, 2026, under FAR Part 12 firm-fixed-price terms. Performance is located in Billerica, Massachusetts.